Overview

Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin

Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
To prospectively demonstrate the superior anxiolytic effect of high dose pregabalin (PGB) therapy (450 mg/day) compared to low dose PGB therapy (150 mg/day) in subjects with medically refractory partial epilepsy not fully controlled despite treatment with 1-2 concomitant antiepileptic drugs (AEDs).
Phase:
Phase 4
Details
Lead Sponsor:
Northeast Regional Epilepsy Group
Collaborator:
Pfizer
Treatments:
Pregabalin